Chen, Qing <br/><br/>
Early Serum HBsAg Drop Is a Strong Predictor of HBeAg Seroconversion and HBsAg Loss to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients with Prior Nucleos(t)ide Analogue Exposure.  [electronic resource] 

 -  Medical science monitor : international medical journal of experimental and clinical research  Jun 2019 
 - 4665-4674 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1643-3750 
<br/><br/><label>Standard No.: </label>10.12659/MSM.916441  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Biomarkers, Pharmacological--blood<br/>DNA, Viral--blood<br/>Female<br/>Guanine--analogs & derivatives<br/>Hepatitis B Surface Antigens--analysis<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B virus--genetics<br/>Hepatitis B, Chronic--blood<br/>Humans<br/>Interferon alpha-2--pharmacokinetics<br/>Interferon-alpha--pharmacology<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--pharmacology<br/>Recombinant Proteins--pharmacology<br/>Seroconversion<br/>Treatment Outcome